SCHEMBL6995974

SCHEMBL6995974

CCCn1c(=O)c2[nH]c(C)nc2n2nc(-c3ccco3)nc12

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.49
LMNA P02545 1/20 0.49
CYP1A1 P04798 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
NFKB1 P19838 1/20 0.49
MAPK1 P28482 1/20 0.49
CYP2C19 P33261 1/20 0.49
BLM P54132 1/20 0.49
PMP22 Q01453 1/20 0.49
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HIF1A Q16665 1/20 0.49
ADORA3 P0DMS8 8/20 0.48
ADORA2A P29274 11/20 0.45
ADORA2B P29275 7/20 0.45
HSF1 Q00613 1/20 0.43
ADORA1 P30542 6/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6997253 0.88 ADORA2A (0.48) ADORA3ADORA2AADORA2BADORA1
SCHEMBL8563585 0.82 ADORA2B (0.54) MEN1CYP1A2CYP3A4CYP2C19KMT2A
SCHEMBL7001583 0.76 ADORA2A (0.49) MEN1CYP1A2CYP3A4CYP2C19KMT2A
SCHEMBL8872400 0.72 ADORA2B (0.69) MEN1CYP1A2CYP3A4CYP2C19KMT2A
SCHEMBL1063544 0.68 SIRT1 (0.68) MEN1LMNACYP1A2CYP3A4CYP2C19
Furafylline SCHEMBL191214 0.66 MEN1 (1.00) MEN1LMNACYP1A1CYP1A2CYP3A4
SCHEMBL25539381 0.66 ADORA2A (0.58) ADORA3ADORA2AADORA2BADORA1
SCHEMBL9585428 0.66 ADORA2B (0.57) MEN1CYP1A2CYP3A4CYP2C19KMT2A
SCHEMBL6999142 0.65 SIRT1 (0.46) MEN1LMNACYP1A1CYP1A2CYP3A4
SCHEMBL1720432 0.65 ADORA2A (0.51) MEN1CYP1A2CYP3A4CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1087973-B1 IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY BOEHRINGER INGELHEIM PHARMA (DE) 2003-01-08 EP claimed
EP-1087973-A1 IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY Boehringer Ingelheim Pharma KG (DE) 2001-04-04 EP claimed
WO-1999065912-A1 IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-12-23 WO claimed
EP-1087973-B1 IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY BOEHRINGER INGELHEIM PHARMA (DE) 2003-01-08 EP disclosed